Nephrocare Health Services Limited Q4 FY26 results deck summary

Results deck of 19 May 2026, summarised by AI from the filing.

FY26 revenue ₹998.8 cr, up 32.2% YoY, with adjusted EBITDA ₹238.1 cr, up 37.6% YoY

Key takeaways

1. FY26 revenue ₹998.8 cr, up 32.2% YoY, driven by 16.6% increase in treatment volumes
2. FY26 adjusted EBITDA ₹238.1 cr, up 37.6% YoY
3. Volume growth Treatments grew 16.6% YoY in FY26
4. Margin Adjusted EBITDA margin improved to 23.8% in FY26 from 22.9% in FY25

Original filing on BSE

Nephrocare Health Services Limited Q1 FY27 results

As filed: Revenue ₹282 cr, EBITDA ₹63.9 cr, PAT ₹32.0 cr, EBITDA margin 22.7%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹282 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹266 cr, EBITDA ₹53.8 cr, PAT ₹30.4 cr, EBITDA margin 20.2%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹266 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.3% in 30 days (Nifty 500: +3.0%).
• Q3 FY26: Revenue ₹260 cr, EBITDA ₹60.9 cr, PAT ₹32.2 cr, EBITDA margin 23.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹260 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +4.5% in 30 days (Nifty 500: −7.8%).

Past price moves after results do not indicate future moves. Not a recommendation.

Nephrocare Health Services Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (12 Aug 2026), Results deck (11 Aug 2026), Results press release (11 Aug 2026)
• Q4 FY26: Earnings call (20 May 2026), Results deck (19 May 2026), Results press release (19 May 2026)
• Q3 FY26: Earnings call (11 Feb 2026), Results deck (10 Feb 2026), Results press release (10 Feb 2026)